AdvertisementCOVID-19 Vaccine Candidate Heads To Widespread Testing In U.S.July 27, 2020Joe PalcafacebookEmailBiotech company Moderna, headquartered in Cambridge, Mass., announced that it is beginning Phase 3 trials of its COVID-19 vaccine. It will enroll up to 30,000 volunteers (Getty Images)
